[Focus: fulminant and subfulminant hepatic insufficiency].
Fellay
M
M
Département de médecine, Hôpital des Cadolles, Neuchâtel.
Kehtari
R
R
D000111:Acetylcysteine / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications / Q000209:etiology; D003131:Combined Modality Therapy; D003422:Critical Care; D006501:Hepatic Encephalopathy / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D006525:Hepatitis, Viral, Human / Q000150:complications; D006801:Humans; D000860:Hypoxia / Q000150:complications; D017114:Liver Failure, Acute / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D016031:Liver Transplantation; D011379:Prognosis
D000111:Acetylcysteine
Mise au point: insuffisance hépatique fulminante et subfulminante.